← Back to Clinical Trials
RecruitingNCT07150923

Supraglottic Airway for Resuscitation Trial

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionNeonatal Resuscitation
SponsorChildren's Hospital of Philadelphia
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment36,503
SexALL
Min Age0 Days
Max AgeN/A
Start Date2026-01-01
Completion2028-09
Interventions
Enhanced Standard of Care ("Enhanced")Enhanced Standard of Care ("Enhanced-Plus")

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is a hybrid type 3 effectiveness-implementation parallel cluster randomized superiority trial designed to compare two strategies to promote early supraglottic airway (SA) rescue during neonatal resuscitation, with a focus on implementation outcomes.

Eligibility Criteria

Population 1: Hospital Staff Population 1a: Clinical providers and administrators who complete study questionnaires Clinical provider 1a inclusion criteria: * Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation * Fluent in English Administrator 1a inclusion criteria * Oversee the care of newborns on a local level (e.g. nurse manager) or a hospital level (e.g. Chief Quality and Safety Officer) * Fluent in English Clinical provider and administrator exclusion 1a criteria: No exclusion criteria Population 1b: Clinical providers who participate in qualitative interviews Clinical provider 1b inclusion criteria: * Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation * Fluent in English Clinical provider 1b exclusion criteria: No exclusion criteria Population 2: Patients who receive neonatal resuscitation at birth Inclusion Criteria: * Inborn (

Related Trials